WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Ownership - Who owns Viking Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viking Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian LianCEO;Pres2026-07-29148,517$33.32
$4.95MSell
Greg ZanteCFO2026-07-2921,217$33.47
$710.13kSell
Marianna ManciniCOO2026-07-2918,217$33.47
$609.63kSell
Neil William AubuchonChief Commercial Officer2026-03-104,475$33.50
$149.91kBuy
Greg ZanteChief Financial Officer2026-01-0513,900$33.38
$464.02kSell
Greg ZanteChief Financial Officer2026-01-0531,961$32.30
$1.03MSell
Brian LianPresident CEO2026-01-0541,276$34.22
$1.41MSell
Brian LianPresident CEO2026-01-056,400$35.07
$224.42kSell
Brian LianPresident CEO2026-01-05132,454$32.29
$4.28MSell
Greg ZanteChief Financial Officer2026-01-051,500$32.09
$48.13kSell

1 of 3

VKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VKTX insiders and whales buy or sell their stock.

VKTX Shareholders

What type of owners hold Viking Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ligand Pharmaceuticals Inc4.99%5,819,383$168.70MInsider
Brian Lian2.21%2,572,441$74.58MInsider
Michael Dinerman0.60%694,116$20.12MInsider
Marianna Mancini0.36%422,760$12.26MInsider
Greg Zante0.18%212,204$6.15MInsider
Rochelle Hanley0.14%160,836$4.66MInsider
Hiroko Masamune0.12%141,063$4.09MInsider
Matthew W. Foehr0.12%135,186$3.92MInsider
Michael Morneau0.10%116,062$3.36MInsider
Lawson MacArtney0.04%51,115$1.48MInsider

1 of 3

VKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VKTX0.06%8.91%Net SellingNet Selling
LEGN0.03%0.44%Net SellingNet Selling
TARS0.11%39.11%Net SellingNet Selling
RCUS0.10%44.15%Net SellingNet Selling
VCYT0.11%53.43%Net SellingNet Selling
View Top Biotech Stocks

Viking Therapeutics Stock Ownership FAQ

Who owns Viking Therapeutics?

Viking Therapeutics (NASDAQ: VKTX) is owned by 0.06% institutional shareholders, 8.91% Viking Therapeutics insiders, and 91.02% retail investors. Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder, owning 5.82M shares representing 4.99% of the company. Ligand Pharmaceuticals Inc's Viking Therapeutics shares are currently valued at $168.70M.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.